Clinical Trial 54547

Clearwater, FL 33763


Summary:

Diabetic Peripheral Neuropathy - Clearwater FL
Click image to enlarge

CYPRESS is a Phase 2 clinical study evaluating the safety and efficacy of RTA 901
(an oral investigational drug) in patients with Diabetic Peripheral Neuropathic Pain (DPNP).


Qualified Participants Must:

• Male/Female ≥ 18 years of age
• Diagnosed with T1DM or T2DM ≥ 1 year prior to screening. 6+ months of chronic pain relating to DPN
• Clinical diagnosis of DPNP - in lower extremities, may include pain that is burning, lancinating, tingling, or shooting (electric shock–like).
• Currently taking only 1 allowed prescribed SOC pain medication for managing DPN


Qualified Participants May Receive:

All study related care at no cost

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.